603998.SS · 方盛制药
China A-shares · RS rating 80 · As of 2026-10-14
| Price | 10.35 CNY |
|---|---|
| 1-day change | -1.0% |
| RS rating (overall / 1M / 3M / 12M) | 80 / 52 / 80 / 63 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 34 / 33 / 25 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +7.0% |
| Distance from 52-week high | +20.4% |
| Market cap (USD) | $677.0M |